Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm
Authors
Keywords
Interleukin-6, Intravenous immunoglobulin, Kawasaki disease, Vascular endothelial cell, Coronary artery aneurysm
Journal
CLINICAL AND EXPERIMENTAL MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-01-09
DOI
10.1007/s10238-018-00544-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic effect of interleukin-17 and tumour necrosis factor-α on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways
- (2018) A. Beringer et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Curcumin reduces the expression of interleukin 1β and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease
- (2018) Mohammad Taghi Palizgir et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a
- (2018) Mitsuru Higa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Factors Predicting Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Lesion in Patients with Kawasaki Disease: Analysis of the Korean Nationwide Multicenter Survey from 2012 to 2014
- (2018) Min Kyu Kim et al. Korean Circulation Journal
- Clinically amyopathic dermatomyositis with rapidly progressive interstitial pneumonia: The relation between the disease activity and the serum interleukin-6 level
- (2017) Hazuki Yasuda et al. JOURNAL OF DERMATOLOGY
- Coronary-Artery Aneurysm in Tocilizumab-Treated Children with Kawasaki’s Disease
- (2017) Tomo Nozawa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease
- (2017) Tian Xie et al. Pediatric Rheumatology
- A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease
- (2015) Qing Ye et al. Arthritis & Rheumatology
- Risk factors for coronary artery abnormalities in children with Kawasaki disease: a 10-year experience
- (2014) Lorna Stemberger Maric et al. RHEUMATOLOGY INTERNATIONAL
- Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo
- (2013) Kazuya Masuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease
- (2012) Yujia Wang et al. ARTHRITIS AND RHEUMATISM
- Prevalence of Kawasaki Disease in Young Adults With Suspected Myocardial Ischemia
- (2012) Lori B. Daniels et al. CIRCULATION
- Tumor Necrosis Factor-α Signaling in Macrophages
- (2012) Narayanan Parameswaran et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis
- (2012) Kee-Soo Ha et al. EUROPEAN JOURNAL OF PEDIATRICS
- Platelet count and erythrocyte sedimentation rate are good predictors of Kawasaki disease: ROC analysis
- (2010) Song Xiu-Yu et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
- (2010) Min Seob Song et al. Korean Circulation Journal
- Clinical application of rapid assay of serum interleukin-6 in Kawasaki disease
- (2008) Yusuke Suganami et al. PEDIATRICS INTERNATIONAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started